Clinical Trial Update: Evaluate Pharmacokinetic/Pharmacodynamic and Safety/Tolerability of AYP-101 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics/pharmacodynamics and safety/tolerability of AYP-101 in healthy subjects, with submental fat as the indication; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Submental Fat

Drugs mentioned

• AYP-101

Snippet

Sponsor: AMIpharm Co., Ltd. | Conditions: Healthy Subjects, Submental Fat | Phase 1 | Status: COMPLETED